-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Arnaud Pigneux, MD, PhD1,2*, Pierre-Yves Dumas, MD, PhD3*, Marc Bernard, MD4*, Norbert Vey, MD5, Audrey Bidet, PharmD6*, Ariane Mineur7*, Mathilde Hunault, MD; PhD8*, Martin Carre, MD9*, Mario Ojeda, MD10*, Anne Banos, MD11*, Pierre Peterlin, MD12*, Romain Guieze, MD, PhD13*, Yohan Desbrosses, MD14*, Gabrielle Roth Guepin, MD15*, Celestine Simand, MD16*, Thibaut Leguay, MD17*, Emmanuel Gyan, MD, PhD18, Eric Jourdan, MD19*, Jean-Philippe Vial, MD20*, Tony Marchand, MD, PhD21*, Yosr Hicheri, MD22*, Marie C Bene, PharmD, DPhil23*, Jean Francois Hamel, MD24* and Christian Recher, MD25

1Hematology Clinic, Bordeaux University Hospital, Pessac, France
2Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
3Department of Clinical Hematology, Bordeaux University Hospital, PESSAC, France
4Hematology Department, CHU de Rennes, Rennes, France
5Paoli-Calmette Cancer Institute, Marseille, France
6Hematology Biology, CHU de Bordeaux, Bordeaux, France
7Bordeaux University Hospital, Bordeaux, FRA
8Clinical Hematology, CHU d'Angers, Angers, France
9Hematology, CHU Grenoble Alpes, La Tronche, France
10Hematology, Mulhouse, FRA
11Service d'Hematologie, Centre Hospitalier De Bayonne, Bayonne, FRA
12Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
13Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
14Service d'Hematologie, CHU de Besançon, Besancon, France
15Service d'Hematologie, CHU de Nancy, Nancy, FRA
16CHU Strasbourg, Strasbourg, FRA
17Bordeaux University Hospital, Pessac, FRA
18Service D'Hematologie et Therapie Cellulaire, CHU de Tours, Tours Cedex, France
19Service d’Hématologie, Centre Hospitalier Universitaire de Nîmes, Nîmes, France
20Hematology Biology, Bordeaux University Hospital, Pessac, France
21Rennes University Hospital, Rennes, France
22Departement d'Hematologie, Institut Paoli-Calmettes, MARSEILLE, France
23Hematology Biology, Nantes University Hospital, Nantes, France
24Centre de Recherche Clinique, CHU Angers, Angers, France
25Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Konstantinos Lontos, MD, PhD1,2, Robert L. Redner, MD2, Mounzer Agha2, Anastasios Raptis, MD2, Jing-Zhou Hou, MD, PhD3, Rafic J. Farah, MD2, Annie Im, MD2, Kathleen Dorritie2, Alison R. Sehgal, MD2, James M. Rossetti, DO2, Daniel Normolle, PhD4* and Michael M. Boyiadzis, MD4

1Stem Cell Transplant & Cellular Therapy, University of Texas, MD Anderson Cancer Center, Houston, TX
2UPMC Hillman Cancer Center, Pittsburgh, PA
3Hematology and BMT, Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
4University of Pittsburgh, Pittsburgh, PA

Sylvain Garciaz, MD PHD1*, Justine Decroocq, MD, PhD2*, Sarah Bertoli3*, Amine Belhabri4*, Pierre-Yves Dumas, M.D., Ph.D.5*, Celestine Simand6*, Kamel Laribi, MD7*, Alberto Santagostino8*, Martin Carre, MD9*, Aline Schmidt10*, Gaspard Aspas Requena11*, Chantal Himberlin12*, Marie-Anne Hospital1*, Christian Recher, MD3 and Norbert Vey, MD1

1Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France
2Service d’Hématologie, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France
3Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France
4Hematology, Centre Leon Berard, Lyon, France
5CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France;BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France, Bordeaux, France
6Clinical Hematology, Strasbourg University Hospital, Strasbourg, France
7Hématologie clinique, CH Le Mans, Le Mans, France
8Hematology, CH de Troyes, Troyes, France
9Hematology, CHU Grenoble Alpes, La Tronche, France
10Department of Hematology, Angers University Hospital, INSERM, CRCINA, University of Angers, Angers, France
11Department of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France
12Hôpital Robert Debré,, CHU de Reims, Reims, FRA

Christian Recher, MD1, Sarah Bertoli, MD; PH.D2*, Pierre Peterlin, MD3*, Romain Guieze, MD, PhD4*, Yohan Desbrosses, MD5*, Yosr Hicheri, MD6*, Omar Benbrahim, MD7*, Martin Carre, MD8*, Hunault-Berger Mathilde, MD, PhD9*, Anne Banos, MD10*, Marc Bernard, MD11*, Emmanuel Gyan, MD, PhD12, Alain Saad, MD13*, Safia Chebrek14*, Gabrielle Roth Guepin, MD15*, Veronique Dorvaux, MD16*, Laurence Sanhes, MD17*, Maria Pilar Gallego Hernanz, MD, PhD18*, Carole Exbrayat, MD19*, Laure Vincent, MD20*, Chantal Himberlin21*, Laetitia Largeaud, PharmD22*, Eric Delabesse, PharmD, PhD23*, Francois Vergez, DVM, PhD24*, Norbert Vey, MD25, Ariane C Mineur, CRA26*, Célestine Simand, MD, PHD27*, Isabelle Luquet, MD28* and Arnaud Pigneux29*

1Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
2Service d'Hematologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
3Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
4Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
5Service d'Hematologie, CHU de Besançon, Besancon, France
6Departement d'Hematologie, Institut Paoli-Calmettes, MARSEILLE, France
7Hematology Department, CHR Orléans, Orleans, France
8Hematology, CHU Grenoble Alpes, La Tronche, France
9Service d'Hematologie, CHU d'Angers, Angers, France
10Service d'Hematologie, Centre Hospitalier De Bayonne, Bayonne, FRA
11Hematology Department, CHU de Rennes, Rennes, France
12Service d'Hematologie et Therapie Cellulaire, CHU de Tours, Tours, France
13CH Béziers, Béziers, France
14service d’onco-hématologie, CH Avignon, Avignon, FRA
15Service d'Hematologie, CHU de Nancy, Nancy, FRA
16Hôpital de Mercy, CHR de Metz-Thionville, Ars Laquenexy, France
17Department of Hematology, CH de Perpignan, Perpignan, France
18Service d'Hematologie, CHU de Poitiers, Poitiers, France
19Institut de Cancérologie Privé, Clinique du Parc, Castelnau-le-Lez, France
20Department of Hematology, Montpellier University Hospital, Montpellier, France
21Hôpital Robert Debré,, CHU de Reims, Reims, FRA
22Laboratoire d'hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse cedex9, France
23Laboratoire d'hématologie, CHU de Toulouse - Institut Universitaire du Cancer De Toulouse-Oncopole, Toulouse cedex9, France
24Laboratoire d'Hematologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse-Oncopole, TOULOUSE, France
25Hematology Department, Institut Paoli-Calmettes, Marseille, France
26FILO study group, Bordeaux, France
27Department of hematology, CHU de Strasbourg - Institut de Cancérologie Strasbourg Europe, Strasbourg, France
28Laboratoire d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
29Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France

Priyanka Mehta1*, Anjum Khan2*, Jamie Maddox, FRCPath, MBBChir, MRCP3*, Yngvar Floisand, MD, PhD4*, Richard Whitmill, FRCPath5*, Daniel Cuadras6*, Montse Pedros6*, Saemi Park7*, Greg Medalla7*, Alex Legg7* and Victoria Louise Campbell, BSc, FRCPath, MBBS, MRCP8*

1University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
2St James's Institute of Oncology, The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
3South Tees Hospitals, NHS Foundation Trust, Middlesbrough, ENG, GBR
4Clatterbridge Cancer Centre, NHS Foundation Trust, Liverpool, United Kingdom
5Royal Wolverhampton, NHS Foundation Trust, Wolverhampton, United Kingdom
6IQVIA Real World Solutions, Barcelona, Spain
7Jazz Pharmaceuticals, Oxford, United Kingdom
8Western General Hospital, Edinburgh, GBR

Naveen Pemmaraju, MD1, Marina Konopleva, MD, PhD2, Kendra Sweet, MD3, Anthony S. Stein, MD4, Sumithira Vasu, MBBS5, David A Rizzieri, MD6, Eunice S. Wang, MD7, Hagop Kantarjian, MD8, Christopher L. Brooks, PhD9, Carole Paley, MD10*, Tariq I. Mughal, MD, FRCP10,11* and Andrew A. Lane, MD, PhD12

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3H. Lee Moffitt Cancer Center, Tampa, FL
4Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
5Division of Hematology, The Ohio State University, Columbus, OH
6Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
7Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
8University of Texas MD Anderson Cancer Center, Houston, TX
9Stemline Therapeutics Inc, New York, NY
10Stemline Therapeutics, New York, NY
11Tufts University School of Medicine, Boston, MA
12Dana-Farber Cancer Institute, Boston, MA

Leila Mohassel, PharmD1, Hanna Yakubi, PharmD1*, Kendra Jones, PharmD, MPH1*, Hongkun Wang, PhD2* and Danielle Shafer, DO3

1Department of Pharmacy, Inova Fairfax Medical Campus, Falls Church, VA
2Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
3Inova Schar Cancer Institute, Inova Fairfax Medical Campus, Falls Church, VA

Hiroyuki Takahashi, MD, PhD1*, Shiro Tanaka, PhD2*, Yuki Yuza, MD, PhD3*, Yuka Iijima-Yamashita, PhD4*, Daisuke Hasegawa, MD, PhD5*, Hiroshi Moritake, MD, PhD6, Kiminori Terui, MD, PhD7*, Shotaro Iwamoto, MD8*, Akira Shimada, MD, PhD9, Jun Matsubayashi, PhD10*, Takao Deguchi, MD, PhD11, Yoshiko Hashii, MD, PhD12, Nobutaka Kiyokawa, MD, PhD13*, Hayato Miyachi, MD, PhD14*, Akiko Moriya Saito, MD, PhD15*, Takashi Taga, MD, PhD16*, Souichi Adachi, MD, PhD17 and Daisuke Tomizawa, MD, PhD18

1Department of Pediatrics, Toho University, Tokyo, Japan
2Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Department of Hematology-Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
4Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, JPN
5Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
6Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
7Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
8Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
9Department of Pediatrics, Jichi Medical University Hospital, Tochigi, Japan
10Center for Clinical Research and Advanced Medicine, Shiga University of Medical Science, Otsu, Japan
11Division of Cancer Immunodiagnostics, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
12Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan
13Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan
14Department of Laboratory Medicine, Tokai University School of Medicine, Isehara, Japan
15Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
16Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
17Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
18Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan

Galia Stemer, MD1,2*, Ofir Wolach, MD3,4,5,6*, Itai Levi7*, Boaz Nachmias8*, Sigal Tavor, MD9*, Jonathan Canaani, MD10,11, Yishai Ofran, MD12,13, Chezi Ganzel14,15*, Tsila Zuckerman, MD16,17, Doaa Okasha, MD18*, Ilana Hellmann, MD19,20*, Tamar Tadmor, MD16,21*, Najib Dally, MD22,23*, Raanan Cohen, MD24*, Jenia Berelovich, MSc25*, Keren Ofek, PhD25*, Noa Rivlin25*, Neta Frankel, PhD25*, Moshe Grunspan25* and Yakir Moshe, MD, PhD26,27*

1Hematology Institute, Galilee Medical Center, Nahariya, Israel
2Bar Ilan faculty of Medicine, Zefat, Israel
3The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Rabin Medical Center, Petah Tikva, Israel
5Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel
6Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
7Institute of Hematology, Soroka University Medical Center, Faculty of Health Sciences, Beersheba, Israel
8Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
9Hemato-Oncology, Assuta Medical Center, Tel Aviv, Israel
10Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
11Hematology Division, Sheba Medical Center, Givatayim, Central, Israel
12Department of Hematology, Shaare Zedek Medical Center, Faculty of Medicine Hebrew University of Jerusalem, Jerusalem, Israel
13Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
14Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
15Shaare Zedek Medical Center, Jerusalem, Israel
16The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
17Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
18Hematology Unit,, Ha’Emek Medical Center, Afula, Israel
19Meir Medical Center, Kfar Saba, Israel
20Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
21Bnai Zion Medical Center, Haifa, Israel
22Azrieli faculty of Medicine, Bar Ilan University, Safed, Israel
23Ziv Medical Center, Sief Medical Center, Safed, Israel
24AbbVie Inc, Hod-Hasharon, Israel
25AbbVie Inc., Hod-Hasharon, Israel
26Sackler faculty of Medicine, Tel Aviv University, Department of Hematology, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
27BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Agnieszka Wierzbowska, MD, PhD1, Agnieszka Pluta, MD, PhD1*, Piotr Stelmach, MD, PhD2*, Marta Anna Sobas, MD, PhD3*, Justyna Rybka, MD, PhD3*, Tomasz Wróbel3, Ewa Zarzycka, MD4*, Witold Prejzner, MD, PhD5*, Jan Zaucha, MD, PhD4*, Andrzej Szczepaniak, MD, PhD6*, Lidia Gil, MD, PhD7 and Sebastian Giebel, MD, PhD8*

1Department of Hematology Medical University of Lodz, Provincial Multi-specialist Oncology and Traumatology Center, Lodz, Poland
2Provincial Multi-specialist Oncology and Traumatology Center Lodz, Poland, Lodz, Poland
3Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
4Department of Hematology and Transplantology, Medical University, Gdansk, Poland
5Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
6Department of Hematology and Bone Marrow Transplantation, Medical University, Poznan, Poland
7Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
8Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice, Poland

Jun Li1*, Qi Han1*, Yanqing Huang1*, Yanhui Wei1*, Jie Zi1*, Lidong Zhao2*, Zhimei Cai2*, Xuzhang Lu3*, Rong Xiao3*, Yanmin Zhang4*, Xiaotian Yang4*, Hao Xu5*, Naitong Sun6*, Wanchuan Zhuang7*, Zhengdong Wu8*, Yuan Xia, MD8*, Yanli Xu9*, Bin He10*, Wei Zhu11*, Fengling Min12*, Yongchun Chen12*, Banghe Ding13*, Peimin Shi14*, Jing Xie14*, Hua Tang15*, Zefa Liu15*, Bingzong Li16*, Yu Sun16*, Hongxia Qiu17*, Limin Duan17*, Chunhua Song, MD,PhD18,19 and Zheng Ge, MD, PhD1

1Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
2Department of Hematology, The First People's Hospital of Lianyungang, Lianyungang, China
3Department of Hematology, Changzhou No.2 People's Hospital, Changzhou, China
4Department of Hematology, Huai'an Second People's Hospital, Huai'an, China
5Department of Hematology, Yancheng No.1 People's Hospital, Yancheng, China
6Department of Hematology, Yancheng Third People's Hospital, Yancheng, China
7Department of Hematology, The Second People's Hospital of Lianyungang, Lianyungang, China
8Department of Hematology, Jiangsu Taizhou People's Hospital, Taizhou, China
9Department of Hematology, Nanjing First Hospital, Nanjing, China
10Department of Hematology, Northern Jiangsu People's Hospital, Yangzhou, China
11Department of Hematology, Xuzhou No. 1 People's Hospital, Xuzhou, China
12Department of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China
13Department of Hematology, Huai'an First People's Hospital, Huai'an, China
14Department of Hematology, Taixing People's Hospital, Taizhou, China
15Department of Hematology, Xinghua City People's Hospital, Taizhou, China
16Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China
17Department of Geriatric Hematology, Jiangsu Province Hospital, Nanjing, China
18Hershey Medical Center, Pennsylvania State University Medical College, Hershey
19Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus

Himachandana Atluri, MD1, Abhishek Maiti, MBBS2, Koji Sasaki, MD2, Naval Daver, MD2, Yesid Alvarado, MD2, Md Feroz Hossain, MD, MS3*, Xuemei Wang, MS4*, Naveen Pemmaraju, MD2, Koichi Takahashi, MD, PhD5, Gautam Borthakur, MD2, Alessandra Ferrajoli2, Nicholas Short, MD5, Hussein A Abbas, MD, PhD2, Farhad Ravandi, MD2, Elias Jabbour, MD2, Michael Andreeff, MD, PhD2, Guillermo Garcia-Manero, MD6, Hagop Kantarjian, MD7, Marina Konopleva, MD, PhD2 and Courtney D. DiNardo, MD, MSCE2

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Lisa M Niswander, MD, PhD1, Perry Chung1*, Caroline Diorio, MD1 and Sarah K Tasian, MD1,2

1Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA

Yaping Zhang1*, Jianyong Li, MD2,3,4,5 and Wenyu Shi1,6*

1Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China
2Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
3Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
4Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
5Department of Hematology,, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
6Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China

Roberto Latagliata, MD1*, Gianluca Cristiano, MD2*, Dorela Lama, MD3*, Susanna Fenu, MD4*, Lorenzo Rizzo, MD5*, Benedetta Cambò, MD6*, Simone Zoletto, MD7*, Francesca Spirito, MD8*, Fabrizio Cavalca9*, Daniele Cattaneo, MD10*, Natalia Cenfra, MD11*, Giulia De Luca, MD12*, Beatrice Esposito Vangone, MD13*, Ambra Di Veroli, MD1*, Raffaele Palmieri, MD14*, Mario Annunziata15*, Olga Mulas, MD16*, Elisabetta Abruzzese, MD17, Alfredo Molteni, MD18*, Monica Piedimonte19*, Ida Carmosino, MD20*, Prassede Salutari, MD21*, Annalisa Biagi, MD22*, Monica Bocchia, MD23*, Michelina Santopietro, MD24*, Gianni Binotto, MD25*, Alessandra Iurlo, MD, PhD26*, Monica Crugnola, MD27*, Marta Riva, MD28*, Anna Lina Piccioni, MD29*, Elena Maria Elli, MD30*, Antonio Curti, MD, PhD31 and Antonella Poloni, PhD, MD32*

1Hematology, Belcolle Hospital, Viterbo, Italy
2Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
3Hematology, AOU Ospedali Riuniti, Università Politecnica Marche, Ancona, Italy
4Hematology Dep. Az. Osp. San Giovanni-Addolorata Rome, Italy, Rome, Italy
5Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
6Hematology and BMT Unit, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy
7Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padua, Italy
8Haematology and Haematopoietic Stem Cells Transplant Unit, AO San Camillo-Forlanini, Rome, Italy
9Hematology Division and Bone Marrow Transplant Unit, San Gerardo Hospital, Monza, Italy
10Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
11Hematology Unit, S. Maria Goretti Hospital, AUSL Latina, Latina, ITA
12UOC Hematology, Santo Spirito Hospital, Pescara, Italy
13UOC Hematology, Università di Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy
14Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
15Hematology, San Giuseppe Moscati Hospital, Aversa, Italy
16Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
17Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, I, Italy
18Division of Hematology, ASST Cremona, Cremona, Italy
19Hematology, "Sant'Andrea" Hospital-Sapienza, University of Rome, Department of Clinical and Molecular Medicine,, Roma, ITA
20Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
21Dipartimento Oncologia Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy
22Hematology, Santa Maria Goretti Hospital – Polo Pontino “Sapienza” University, Latina, Italy
23Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
24U.O. di Ematologia e Trapianti di cellule Staminali. A.O.S. S. Camillo-Forlanini, Rome, Italy
25Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
26Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
27Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
28Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
29Hematology, San Giovanni Hospital, Rome, ITA
30Hematology Division and Bone Marrow Transplant Unit. San Gerardo Hospital, ASST Monza, Monza, Italy
31Department of Hematology and Oncology Institute of Hematology L. e A. Seràgnoli, Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy
32Hematology, Università Politecnica delle Marche - AOU Ospedali Riuniti, Ancona, ITA

Michael Philippe, PhD, PharmD1*, Jerome Guitton2*, Bertrand Favier, PharmD, PhD3*, Clemence Santana, MD4*, Emmanuelle Nicolas-Virelizier, MD5*, Yann Guillermin, MD6*, Anne-Sophie Michallet, MD, PhD7*, Mauricette Michallet, MD, PhD5,8 and Amine Belhabri5*

1Centre Leon Berard, Lyon, FRA
2Biochemistry and Pharmacology-Toxicology Laboratory, Lyon Sud Hospital, Pierre Benite, France
3Department of Pharmacy, Centre Leon Berard, University Claude Bernard Lyon 1, Lyon, France
4Hematology, Centre Leon Berard, LYON, FRA
5Hematology, Centre Leon Berard, Lyon, France
6Hematology Department, Centre Léon Bérard, Lyon, France
7Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France
8Centre Leon Berard, Centre Léon Bérard, Hematology Department, Lyon, France

Diana Abbott, PhD1*, Grace Bosma2*, Christine M. McMahon, MD3, Marc Schwartz, MD4, Jonathan A. Gutman, MD5 and Daniel A. Pollyea, MD6

1Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
2Department of Biostatistics and Bioinformatics, University of Colorado Anschutz Medical Campus, Aurora, CO
3Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
4University of Colorado, Denver, CO
5Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO
6Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Denver, CO

Vikram Dhillon, DO1*, Abdul Moiz Khan, MD2, Ali Al Sbihi, MD1*, Sushmitha Nanja Reddy, MBBS1*, Enxhi Lalo3*, Harry Ramos3*, Jay Yang, MD4, Anupama Kottam, MD5* and Suresh Kumar Balasubramanian, MD4

1Department of Internal Medicine, Wayne State University, Detroit, MI
2Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
3School of Medicine, Wayne State University, Detroit, MI
4Department of Oncology, Karmanos Cancer Institute, Detroit, MI
5Department of Cardiology, Wayne State University, Detroit, MI

Christine M. McMahon, MD1, Kellen Gil2*, Maria L. Amaya, MD, PhD3, Jonathan A. Gutman, MD4, Alexander Hayden5*, Marc Schwartz, MD6, Grace Bosma7*, Diana Abbott, PhD8*, Brett M. Stevens, PhD1, Clayton Smith, MD9*, Craig T Jordan, PhD10 and Daniel A. Pollyea, MD, MS11*

1Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
2Department of Medicine, University of Colorado, Denver, CO
3Anschutz Medical Campus, Division of Hematology, University of Colorado, Aurora, CO
4Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO
5Department of Medicine, University of Colorado, Aurora, CO
6University of Colorado, Denver, CO
7Department of Biostatistics and Bioinformatics, University of Colorado Anschutz Medical Campus, Aurora, CO
8Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
9Division of Hematology, University of Colorado, Aurora, CO
10University of Colorado, Aurora, CO
11Department of Hematology, University of Colorado, Aurora, CO

Emily Geramita, MD, PhD1, Hong Wang, PhD1*, Melissa Bastacky, PharmD1*, Jessica Cohen, MD1, Rory M. Shallis, MD2, Talha Badar, MD3, Mark R. Litzow, MD4 and Annie Im, MD1

1University of Pittsburgh Medical Center, Pittsburgh, PA
2Yale University School of Medicine, New Haven, CT
3Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
4Division of Hematology, Mayo Clinic, Rochester, MN

Ali Al Sbihi, MD1*, Sushmitha Nanja Reddy, MBBS2*, Vikram Dhillon, DO1*, Enxhi Lalo3*, Harry Ramos3*, Abdul Moiz Khan, MD4 and Suresh Kumar Balasubramanian, MD4

1Department of Internal Medicine, Wayne State University, Detroit, MI
2Department of Internal Medicine, Wayne State University, Novi, MI
3School of Medicine, Wayne State University, Detroit, MI
4Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI

*signifies non-member of ASH